New Jersey Cancer Care Joins Regional Cancer Care Associates
Affiliation provides oncology practice with expanded resources as it pursues its commitment to providing patients with the latest therapies and best possible outcomes.
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Mesothelioma is a cancer that develops in the mesothelium, the thin tissue lining vital internal organs such as the heart, lungs, and liver. Mesothelioma is rare, with the American Cancer Society estimating that there are about 3,000 new cases each year in the United States.
At Regional Cancer Care Associates (RCCA), patients can receive the latest treatments for a wide range of cancer types, including mesothelioma, from board-certified medical oncologists and hematologists. The team is skilled in providing comprehensive and compassionate care at multiple community-based clinics across New Jersey, Connecticut, Maryland, and the Washington, D.C., area.
Mesothelioma is an aggressive cancer that attacks cells in the mesothelium. The disease typically is not diagnosed until it has spread widely throughout the body.
Because mesothelioma is rare, it long has been misunderstood and often went unrecognized or misdiagnosed. In fact, the cancer was not called mesothelioma until 1909, and research into its cause did not begin until the 1960s. However, the earliest cases were recorded in the 18th Century.
With research advances, doctors have identified several types of mesothelioma based on the location of the disease. These variations include:
Doctors also categorize mesothelioma by cancer cell type. These three types are biphasic, epithelioid, and sarcomatoid. Mesothelioma sometimes is called malignant mesothelioma because there also is a non-cancerous (benign) version of the disease.
Nearly all cases of mesothelioma start with asbestos exposure. Asbestos is a very durable, fire- and water-resistant material that was used to produce many consumer items during the 20th Century. When health researchers realized the damaging effects of this material, mining to obtain asbestos ceased in the U.S., but the material remains in some older homes and buildings.
Many people who develop mesothelioma encountered asbestos at work. Materials containing asbestos can release microscopic fibers into the air. Over time, the cumulative amount of asbestos these individuals inhale or ingest can cause mesothelioma. Family members of these workers can also develop the disease; doctors believe this happens because asbestos can stick to workers’ clothing, enabling asbestos to be brought into the workers’ homes where family members may inhale particles of the material.
Living in a home or building that contains asbestos materials, such as in insulation, also can cause mesothelioma. Some people experience the disease after living in areas near asbestos mines or factories or with natural asbestos deposits.
Other risk factors for developing mesothelioma include:
Mesothelioma often is difficult to detect in its early stages because many people do not display noticeable symptoms until the disease has advanced and the tumor begins affecting nearby organs and tissues. Signs of mesothelioma may not appear until 20 to 50 years after asbestos exposure.
Most patients with mesothelioma experience fatigue, fever, a loss of appetite, and unexplained weight loss. Other common symptoms include:
Symptoms can vary depending on the location of the tumor. Below are common signs and symptoms for different types of mesothelioma:
Physicians use four primary stages to classify mesothelioma at diagnosis and in monitoring the patient subsequently. A higher number correlates with a greater progression of mesothelioma. Most patients have stage III or IV mesothelioma when diagnosed. The staging system varies slightly depending on the type of mesothelioma, but the general approach is as follows:
Many doctors use the TNM system to stage mesothelioma. TNM refers to the three components that are considered in this approach to staging cancer:
While no cure currently exists for mesothelioma, treatment can extend survival, reduce the number and impact of tumors, help minimize symptoms, enhance quality of life, and, particularly in later stages, reduce pain.
Most physicians take a multidisciplinary approach to treating mesothelioma, combining surgical and non-surgical methods. However, some patients may benefit solely from medical treatment. Two of the most effective non-surgical options for treating mesothelioma are:
Physicians may recommend surgery to treat mesothelioma. As noted, surgery often is part of multimodal therapy, which means a combination of two or more cancer treatments. The primary goal of surgery is to remove tumors and the nearby tissues affected by mesothelioma. Especially when combined with other treatments, surgery can significantly improve survival.
Patients have different surgical options based on their specific health needs and the purpose of receiving treatment. In addition to removing cancerous cells, doctors also may suggest surgery to improve symptoms and enhance quality of life.
For patients who do not respond well to traditional surgical and non-surgical treatments, clinical trials are available to evaluate the safety and effectiveness of emerging therapies. These clinical trials reflect the continued efforts of medical researchers to advance mesothelioma treatment. Two options include:
Because mesothelioma is difficult to detect before it has progressed, treating the cancer is challenging. Additionally, the various treatment options can produce side effects. From diagnosis to treatment, patients regularly look for ways to cope with mesothelioma. The following are some options:
From trouble sleeping to nausea and fatigue, cancer and its treatment can cause many bothersome symptoms. Palliative care aims to make living with mesothelioma more comfortable by offering medications and therapies that alleviate symptoms and side effects. Many patients find that palliative care enables them to maintain a more fulfilling life while managing mesothelioma.
Even if palliative care is not necessary, many patients benefit from working with a physiotherapist to better manage pain associated with mesothelioma and treatment. These healthcare professionals can help patients live more comfortably by showing them how to move in ways that prevent or reduce pain. Pain management also may involve guidance with taking medications, whether orally, intravenously, or by another method.
A cancer diagnosis can take a heavy toll on mental and emotional health, as well as physical health. Patients who feel anxious, overwhelmed, or uncertain at any point may consider the following strategies:
Many patients wonder about the prognosis of mesothelioma. The 5-year relative survival rate looks at how likely it is for a person diagnosed with a specific cancer to live for at least 5 years compared to someone without cancer.
Survival rates differ depending on a cancer’s stage. The American Cancer Society reports that the estimated 5-year relative survival rate of mesothelioma at each stage is:
Survival rates are not a surefire indication of how long a person will live with mesothelioma, nor are they representative of the experiences of all patients. These values are estimates based on the outcomes of large numbers of past cases. For further information on the 5-year relative survival rate and how it applies to their diagnosis, patients should talk with their medical oncologist.
Most people are older when diagnosed with mesothelioma, although doctors sometimes detect it in younger patients. The average age at diagnosis of pleural mesothelioma is 72 years.
The most effective way to prevent mesothelioma s is to limit asbestos exposure. For example, workers can reduce the likelihood of inhaling or ingesting asbestos by using personal protective equipment (PPE) when handling materials that could contain asbestos. Companies can educate themselves on asbestos safety to promote a healthier workforce.
Researchers have not found a clear link between smoking and mesothelioma. However, a link exists between smoking and increased risk of lung cancer and other lung diseases. The combined factors of asbestos exposure and smoking can heighten the risk of developing mesothelioma, as smoke inhalation can impact how the body responds to asbestos fibers.
Regional Cancer Care Associates’ medical oncologists and hematologists have extensive experience treating a range of cancers and blood disorders. Committed to providing comprehensive and compassionate care, these doctors work to understand the unique health situations and concerns of each patient and then develop and implement individualized treatment plans. For patients who need assistance with the costs of treatment, RCCA also offers financial information to provide more peace of mind about affording care.
With more than 20 community-based locations across New Jersey, Connecticut, Maryland, and the Washington, D.C., area, patients can find care close to home at RCCA. For more information about mesothelioma treatment and other services, contact RCCA or visit one of the nearest locations for care.
Experienced, compassionate and dedicated to the communities they serve — that describes the doctors at Regional Cancer Care Associates (RCCA). Our doctors focus on every patient, individually, and will work with you and your family to make sure your care is second to none. At RCCA, you’ll be diagnosed and treated by experts who are part of one of the largest cancer care networks in the country. And you’ll receive high-quality, comprehensive and advanced treatment close to home.
You can talk with us by calling (844) 346-7222. You can also schedule an appointment and get more information by calling the RCCA location nearest you.
Affiliation provides oncology practice with expanded resources as it pursues its commitment to providing patients with the latest therapies and best possible outcomes.
Prostate cancer is challenging, but patients who receive an early diagnosis often have a favorable outlook thanks to the ability to receive treatment in the
The American Cancer Society estimates that more than 153,000 cases of colorectal cancer (CRC) will be diagnosed
When standard cancer treatments aren’t providing the results you want, clinical trials may offer hope. Our physicians use clinical trials to study new treatments, helping transform cancer care for the better. You can enroll in a clinical trial to try groundbreaking treatment plans at zero cost to you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.